
What happened
Warby Parker Inc. (NYSE: WRBY) co-Chief Executive Officer and director Neil Harris Blumenthal sold 100,000 Class A shares on 2026-10-01. The shares sold in several transactions at prices from $27.00 to $28.25. The Form 4 lists an average execution price of $27.69 and total value of about $2.77 million.
The form also shows a 95,614-share Class A acquisition at $0 tied to a conversion transaction from Class B stock. That put Blumenthal at 136,020 shares before the sale. After the sale, he held 36,020 shares. The filing says the trades were made under a Rule 10b5-1 plan adopted on March 17, 2026.
Key numbers
| Metric | Latest | Change | Source |
|---|---|---|---|
| Shares sold | 100,000 shares | SEC Form 4 | |
| Average execution price | $27.69 per share | SEC Form 4 | |
| Sale price range | $27.00 to $28.25 per share | SEC Form 4 | |
| Total sale value | about $2.77 million | SEC Form 4 | |
| Shares held after sale | 36,020 shares | SEC Form 4 |
Read more: Warby Parker (WRBY) stock analysis and investment case
Why it matters
OptimistFi's case is that Warby Parker can create value if its brand-led, healthcare-adjacent eyewear model keeps taking share while growth turns into durable GAAP operating profit and cash. This filing is mixed for that view. The 100,000-share sale was about 73.5% of the holding before the trade, so it was large relative to the stake shown in the form.
The same-day conversion explains the 136,020-share direct stake before the sale. The Rule 10b5-1 plan was adopted months before the trade, so it is the main caveat here. The filing is a trading disclosure, not a business update, so it says more about ownership than about operations.
That makes the sale a mixed signal rather than a clear view on the company.
Browse: stock research on every company OptimistFi covers
What's next
Warby Parker's next quarterly report is the next test after this filing. Results that show growth still converting into GAAP operating profit and cash would strengthen OptimistFi's case. A weaker report would weaken it. That is the metric set OptimistFi says matters most.
More from OptimistFi
- WRBY stock: the Warby Parker thesis, its status and the next test to watch
- Century Therapeutics, Inc. (NASDAQ: IPSC) Adds Two CNTY-813 Batches
- Applied Digital Corporation (NASDAQ: APLD) Brings 250 MW Online
- ON Semiconductor Corporation (NASDAQ: ON) Cuts Its Deal Cost by 19%
- Stock research on every company OptimistFi covers
- Latest stock research and investment-case updates
- OptimistFi: evidence-first equity research
Sources
- SEC Form 4 — Form 4 reporting Blumenthal's sale, post-sale holdings and Rule 10b5-1 plan.
Read the full OptimistFi thesis on Warby Parker Inc.: https://optimistfi.com/stocks/WRBY
See what would break the Warby Parker Inc. thesis and track it live on the OptimistFi Thesis-Break Engine.
Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research.
The full Warby Parker Inc. investment case, its status and the next test to watch live on the Warby Parker Inc. thesis page.
Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.
